Objective: To investigate the effects of pretreatment with growth hormone (GH) and insulin-like growth factor I (IGF-I) on phagocyte exudation and bacterial clearance, focusing on CD11b and CD32/CD16 expression on local and systemic phagocytes, in a lethal peritonitis model. Design: Prospective randomized experimental study. Setting: Research laboratory in a university hospital. Subjects: Balb/c mice (n = 21). Interventions: Mice were challenged intraperitoneally with 1 x108 Escherichia coli, after 6 days of pretreatment with saline (control), GH (4.8 mg/kg/day), or IGF-I (24 mg/kg/day). Samples were harvested at 4 hrs after the challenge. Measurements and Main Results: Viable bacterial counts in peritoneal lavage fluid (PLF) and blood were determined. Peritoneal exudative cells and peripheral blood leukocytes were counted and analyzed for receptor expressions by flow cytometry. GH reduced viable bacterial counts in PLF, as compared with the saline control. GH (three-fold) and IGF-I (two-fold) increased the number of peritoneal exudative neutrophils (PENs), as compared with the saline control. The number of PENs showed an inverse correlation with PLF viable bacterial counts. By contrast, there were no differences in peripheral blood neutrophil (PN) counts among the three groups, nor was there a correlation between PN and PEN counts. CD11b expression was greater on PENs than on PNs in all three groups. CD11b expression on PNs did not differ among the three groups. However, GH increased CD11b expression on PENs, as compared with saline and IGF-I, and this expression showed a positive correlation with PEN numbers and an inverse correlation with PLF viable bacterial counts. CD11b expression on peritoneal macrophages and peripheral blood monocytes did not differ among the three groups. There were no differences in phagocyte CD32/CD16 expression among the three groups. Conclusions: GH pretreatment enhanced CD11b expression on PENs, but not PNs, possibly in association with enhanced neutrophil recruitment, phagocytosis, and bacterial elimination by PENs, without activation of PNs. GH prophylaxis may be useful for reducing the frequency rate and severity of septic complications, via modulation of CD11b expression on local and systemic neutrophils. (Crit Care Med 1998; 26:338-343) Postoperative septic complications are the most frequent complications in patients undergoing major surgery [1]. Moreover, these complications often occur in patients with malnutrition [2,3], particularly those patients with gastrointestinal disorders [4], or the elderly [5,6]. Therefore, it is important to recognize patients at risk for septic complications preoperatively, and to prophylactically reduce the frequency rate and severity of such disorders, as well as to manage them after the onset. Growth hormone (GH) and insulinlike growth factor I (IGF-I) have been used in catabolic states because of their anabolic properties [7-9]. In addition, these hormones have several immunomodulatory effects [10-13]. Low serum/plasma GH and IGF-I concentrations have been demonstrated in aged populations [14], and low plasma IGF-I concentrations are also related to malnourished states [15,16], with both age and malnutrition increasing the risk of septic complications, as mentioned above. In such patients, therefore, prophylaxis with GH or IGF-I may effectively prevent postoperative septic complications. Ziegler and Leader [17] also mentioned the ICU patient groups as at risk for infection (e.g., severe catabolic illness, malnourished patients hospitalized with catabolic illness or injury, or elderly patients requiring major operations), in whom it would be worthwhile to determine whether GH improves immune cell function and/or reduces the frequency rate or severity of infection. Among septic complications, we focused on severe peritonitis, which has a high mortality rate despite recent improvements in surgical management [18,19]. In peritonitis, host defense mechanisms may be improved by enhancing the bactericidal activities of peritoneal phagocytes (macrophages and neutrophils), which represent the first line of host defense [20]. On the other hand, activated neutrophils in remote organs can cause tissue injury [21,22]. Therefore, new prophylactic strategies may require the control of phagocyte exudation and modulation of the activities of local and systemic phagocytes in severe bacterial peritonitis. Surface opsonin receptors play critical roles in the recruitment and activation of phagocytes. CD11b (alpha M subunit of Mac-1, complement receptor 3) is involved in iC3b binding, phagocytosis and reactive oxygen production, in addition to the neutrophilendothelium binding essential to neutrophil exudation [23-25]. CD32 and CD16 (immunoglobulin G [IgG] Fc receptors II and III, respectively) are also involved in activating phagocytosis and the bactericidal activity of phagocytes [26,27]. Therefore, it may be worthwhile to focus on the expression of these opsonin receptors on local and systemic phagocytes to devise strategies for preventing severe bacterial peritonitis. We [28] previously showed that GH and IGF-I pretreatments enhanced host defense and prolonged the survival of mice with lethal peritonitis. In that study [28], both hormones, especially GH, markedly reduced peritoneal bacterial counts with increased numbers of peritoneal exudative cells (PECs) at 4 hrs after the onset of peritonitis. The aim of the present study was to investigate the mechanisms of peritoneal bacterial reduction with enhanced phagocyte exudation, at the 4-hr time point, by GH and/or IGF-I pretreatments. We focused on CD11b and CD32/CD16 expression on local and systemic phagocytes in the same murine peritonitis model.